Femara

Femara (Letrozole) is an oral medication used to treat certain types of breast cancer in postmenopausal women. It works by reducing estrogen levels in the body, which can help slow or stop the growth of cancer cells.

Femara is primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It is often prescribed after surgery or other treatments to reduce the risk of cancer recurrence. Letrozole is also used to manage breast cancer that has spread to other parts of the body. The medication is designed to lower estrogen levels, which can help inhibit the growth of cancer cells that rely on this hormone.

Common effects of Femara may include hot flashes, joint pain, fatigue, and hair thinning. Some users may also experience nausea, headaches, or dizziness. These effects can vary in severity and duration, and not everyone will experience them. It's important to discuss any persistent or bothersome effects with a healthcare provider.

Femara should be used with caution in individuals with a history of osteoporosis or liver disease. Regular bone density monitoring may be recommended due to the potential risk of bone thinning. It is important to follow the prescribed dosage and not to stop taking the medication without consulting a healthcare provider.

Femara may interact with certain medications, including estrogen-containing therapies, tamoxifen, and some drugs metabolized by the liver. It is important to inform your healthcare provider about all medications, supplements, and herbal products you are taking to avoid potential interactions. Alcohol consumption should also be discussed with a healthcare provider.